YDES YD Bio Limited
$4.00▲ +2.56%
Healthcare
Other
After hours
$4.00▲ +0.00%
Sep 11, 7:30 PM ET
Volume 819.3K
Avg Volume (10D) 570.4K
Key Metrics & Fundamentals
Market Cap
$283.33M
P/E Ratio
–
Div Yield
–%
52W Range
1.70 - 23.00
% vs 50 MA
33.95%
% vs 200 MA
-40.11%
RSI-14
54.9
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.60
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
GlobeNewswire · Aug 31, 2026 10:00 PM
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
GlobeNewswire · Aug 25, 2026 12:00 PM
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
GlobeNewswire · Aug 11, 2026 12:00 PM
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
GlobeNewswire · Aug 4, 2026 12:00 PM
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
GlobeNewswire · Jul 28, 2026 12:00 PM
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
GlobeNewswire · Jul 23, 2026 12:00 PM
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
GlobeNewswire · Jul 2, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for YDES.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.